Adenoma Detection Rate Tied to CRC Risk After Positive FIT
TUESDAY, Sept. 27, 2022 (HealthDay News) — The adenoma detection rate (ADR) of endoscopists is associated with the risk for interval postcolonoscopy colorectal cancers (PCCRCs) after a positive fecal immunochemical testing (FIT) result, according to …
Learn MoreRace-Free Creatinine Equation May Cut Disparity in Kidney Wait Time
TUESDAY, Sept. 27, 2022 (HealthDay News) — Use of the creatinine race-free 2021 Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation to determine eligibility for the kidney transplant wait list may reduce racial differences in preempt…
Learn MoreHappiness From Home Buying Is Often Fleeting, Study Shows
TUESDAY, Sept. 27, 2022 (HealthDay News) — Home ownership may be the culmination of the American Dream, but a new study cautions that many people think they will be happier than they actually become once they are king or queen of their own castle.“We…
Learn MoreBivalent mRNA-1273.214 Elicits Better Response Against Omicron
TUESDAY, Sept. 27, 2022 (HealthDay News) — Interim results of an ongoing study show that use of the bivalent omicron-containing vaccine mRNA-1273.214 as a second booster elicits neutralizing antibody responses against omicron that are superior to tho…
Learn MoreApixaban Noninferior to Enoxaparin for Postoperative VTE Prophylaxis
TUESDAY, Sept. 27, 2022 (HealthDay News) — Apixaban is noninferior to enoxaparin for extended-duration venous thromboembolic event prophylaxis (EP) after abdominopelvic oncologic surgery, according to a study published in the October issue of The Jou…
Learn MoreSemaglutide Reduces 10-Year Risk for T2D in Obese Persons
TUESDAY, Sept. 27, 2022 (HealthDay News) — Semaglutide reduces the 10-year risk for type 2 diabetes (T2D) in obese or overweight individuals, and sustained treatment is needed to maintain this risk reduction, according to a study presented at the ann…
Learn MoreMetachronous Pathology Assessed in Young-Onset CRC Survivors
TUESDAY, Sept. 27, 2022 (HealthDay News) — The incidence rate of clinically significant metachronous colorectal pathology is 32 per 1,000 person-years after index young-onset colorectal cancer (YOCRC), according to a research letter published online …
Learn MoreTriplet Therapy Ups Progression-Free Survival in Advanced Kidney Cancer
MONDAY, Sept. 26, 2022 (HealthDay News) — Triplet therapy of cabozantinib + nivolumab + ipilimumab significantly improves progression-free survival (PFS) compared with placebo + nivolumab + ipilimumab for patients with previously untreated advanced r…
Learn MoreCoffee Might Perk Up Your Heart and Life Span
TUESDAY, Sept. 27, 2022 (HealthDay News) — Folks who drink two or three cups of coffee daily appear to live longer than people who don’t care for the beverage, new research shows.Coffee lovers also seemed to have healthier hearts, which might contrib…
Learn MoreBiden Administration Announces National Plan to End Hunger By 2030
TUESDAY, Sept. 27, 2022 (HealthDay News) — The White House on Tuesday released a national plan to end hunger by 2030, an ambitious goal that would be accomplished largely by expanding monthly food benefits for poor Americans.The plan would also aim t…
Learn More